175 results
Page 5 of 9
S-8
s17bx1rwsl5aozqli
3 May 22
Registration of securities for employees
4:35pm
S-8
i4bss99gwfg63y4
3 May 22
Registration of securities for employees
4:35pm
8-K
EX-10.1
ntka6 91lp2q2a
26 Apr 22
Departure of Directors or Certain Officers
6:51am
8-K
EX-3.2
uqt7vb90oqt68r5k
8 Nov 21
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s
7:32am
8-K
EX-2.1
hmotq9
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
8-K
tlmm9wx yy0
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
424B5
irxnx
11 Aug 21
Prospectus supplement for primary offering
6:56am
8-K
EX-4.1
6hm9hjug4
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.2
d8e zxwbq15q8zd54f8
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-4.2
gmjjtzp8klr64nw
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.1
jkk7j466z9
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-99.1
oppp1 a4uclzt07p6r
27 May 21
Regulation FD Disclosure
7:01am
424B3
y6u3akzf5yi dc
30 Apr 21
Prospectus supplement
5:01pm